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that underlie the development of pathological cardiac hypertrophy, and related loss of function, all of the factors contributing to disease pathology remain incompletely understood (6) .
We have used a consomic rat model to study the genes regulating LVH in a controlled genetic environment (1) BN /Mcwi were also better protected from developing left ventricular fibrosis by 36 wk of age and had a higher capillary-to-fiber ratio at 18 wk of age (18) .
Despite the striking phenotypic differences between the SS-16 BN /Mcwi and their parental strains, the results of our previous study were not able to determine if BN/NHsdMcwi chromosome 16 substitution in the SS/Mcwi genome provided cardioprotection directly through altered gene-gene interaction or was secondary due to the lower blood pressure in the SS -16 BN /Mcwi. In the current study, we hypothesized that the gene expression pattern resulting from the unique combination of BN chromosome 16 and SS/Mcwi genomes in the SS -16 BN / Mcwi provides cardioprotection to these animals even in the presence of increased afterload. Additionally, we aimed to identify genes that were differentially expressed in left ventricle tissue from naïve SS/Mcwi and SS -16 BN /Mcwi rats to better understand the molecular mechanisms conferring the cardioprotection in the genetically protected model. All animal protocols were approved by the MCW Institutional Animal Care and Use Committee. For all procedures rats were anesthetized by an intramuscular injection of ketamine (100 mg/kg), xylazine (50 mg/kg), and acepromazine (2 mg/kg).
Surgical models of LVH. The 1-kidney, 1-clip (1K1C) surgery was performed with silver clips as previously described by Brooks et al. (2) to induce cardiac hypertrophy in 9 wk old rats SS-16 BN /Mcwi and SS-13 BN /Mcwi. (n ϭ 5/strain). Sham operation was also performed (n ϭ 5-7/strain). The contralateral kidney was then excised after a 3-0 silk suture was tied around the renal artery and vein. Animals were studied and tissues were harvested 2 wk after surgery. The placement clips was verified post mortem.
Wall thickness and blood pressure measurements. Transthoracic echocardiography (Vivid 7, GE) was performed on anesthetized SS-16 BN /Mcwi and SS-13 BN /Mcwi and rats prior to 1K1C surgery and at 9 wk of age. Short-axis views of left ventricles were acquired midpapillary. Wall thickness was measured from the M-mode view. Sham surgery or 1K1C surgery was completed on animals, and they were allowed to recover. Two weeks following surgery animals were anesthetized and ultrasound measurements of the left ventricle were repeated. At this time blood pressure was measured in the carotid artery using a SPR-838 Millar Mikro Tip catheter (Millar Instruments). Blood pressure analysis was completed with ADInstruments Chart software.
Tissue collection and fibrosis measurement. The heart was excised rapidly, placed in 500 mM KCl, and weighed. Atria were removed, and the wet weight of the ventricles was taken. The ventricles were then cut in cross section midventricle, fixed in 10% formalin, mounted in wax, sliced, and rehydrated before trichrome staining was performed. Images of the slide-mounted sections were visualized with a Nikon E-400 microscope (Nikon Instruments) and acquired using a SPOT Insight digital camera (Diagnostic Instruments). Fibrotic tissue was quantified as a percent of left ventricle tissue area with Metamorph software (Molecular Devices).
RNA isolation and microarray. Left ventricle tissue was collected from 8 wk old male rats (n ϭ 6 SS-16 BN /Mcwi and n ϭ 6 SS/Mcwi) following decapitation and placed immediately in ice-cold RNAlater (Qiagen). Left ventricle tissue from each animal was cut into pieces ϳ1 mm 3 and stored in 10 ml of RNAlater for 24 h. Tissue pieces were then isolated, snap-frozen in liquid nitrogen, and stored at Ϫ80°C.
Total RNA was extracted from the homogenized (Polytron) cardiac tissue of each heart using TRIzol (1 ml per 100 mg of tissue). Pools were created by combining equal amounts of RNA from all six animals from each strain. Each pool was then divided into two technical replicates. These samples were prepared for hybridization to the microarray chips by the Microarray Service Center at the Medical College of Wisconsin according to recommendations by Affymetrix. Briefly, double-stranded cDNA was generated from the singlestranded RNA and purified by according to the Affymetrix protocol. Biotin-labeled cRNA was then synthesized by in vitro transcription, purified, and quantified. BN /Mcwi chips and a signal log ratio was generated for gene expression between each chip-to-chip comparison. Chip-to-chip comparisons for each gene were sorted by signal log ratio.
Pathway analysis of microarray results. Microarray expression data was analyzed by the Significance Analysis of Microarrays (SAM) approach (32) . Genes with expression differences having a delta value of 1 or less were defined as differentially expressed genes. Pathway analysis of these genes was completed by entering their expression values into Ingenuity Pathway Analysis (IPA) software (Ingenuity).
Real-time PCR analysis. Real-time PCR was performed for JunD mRNA (forward primer 5=-CTCCTCCTCCCGACACCATC-3=; reverse primer 5=-TCGTAGCAAAACAAAACCAAACAA-3=) using SYBR Green chemistry and normalized to 18S rRNA expression, as previously described (19) .
JunD sequencing. Total genomic DNA was extracted from tissue obtained from a tail tip as described previously (27) . The following primer pairs F1-5=-TCAACGTGGGTTACATCTTTTG, R1-5=-CTACTTAGCGCCCTGTCAGTTT; F2-5=-ACACTTGGGGAGAT-GAAAACAG R2-5=-GCGCGCACTCTTATAGCC; F3-5=-CAT-GACGTCAACCCACAATG, R3-5=-AACTGCTCAGGTTGGCG-TAG; F4 -5=-ATCTTGGGCTGCTCAAACTC, R4 -5=-GGGTCCA-GCTTGTCGAGTC, F5-5=-GGAGAAAGTCAAGACCCTCAAA, R5-5=-GAGCACTTCGCTCTACTCCTTC; F6 -5=-GCCGGTTTTGT-GTTTTCAGTA, R6 -5=-AACTGGGACTTACCATGTGACC; F7-5=-CTGACCCGGAACTCAGAGA, R7-5=-AGTGAAGACACTGGTG-TATGTGG were used to amplify a 4,793 kb genomic region of JunD including 1,582 kb of upstream untranslated region. The product sizes of the resulting overlapping PCR amplicons ranged from 949 to 999 bp. The unpurified PCR products were employed in sequencing reactions performed on a Bio-Rad DNA Engine Tetrad thermocycler under the following conditions: 96°C for 10 s, 50°C for 5 s, 60°C for 4 min for a total of 25 cycles. The sequencing reaction products were purified using the Millipore Montage clean-up kit and a Beckman Coulter Biomek FX. DNA sequencing was performed using an Applied Biosystems 3730xl DNA Analyzer. All fragments were sequenced from both strands. Sequencing analysis was performed as previously described (27) .
Western blots. Left ventricles were isolated from anesthetized 8 wk old male rats (n ϭ 14 SS-16 BN /Mcwi, n ϭ 11 SS/Mcwi) and snap-frozen in liquid nitrogen until time of homogenization. The frozen hearts were minced and then homogenized in a 1:3 volume of solubilization buffer [0.32 M sucrose, 10 mM Tris·HCl (pH 7.4), 1 mM DTT, 1 mM EGTA, 1 mM EDTA, 1 protease inhibitor tablet (Roche) per 100 ml of buffer] on ice for 30 s with a Polytron homogenizer. For SOD-2, catalase, Flt-1, and vascular endothelial growth factor (VEGF) Western blots, the whole tissue homogenate was stored at Ϫ80°C until Western blots were run. To enrich samples for nuclear protein for the JunD Western blots, whole tissue homogenate was centrifuged at 4°C and 1,000 g for 10 min. The supernatant was removed and the nuclear protein-enriched pellet was solubilized in Triton buffer [1% Triton X-100, 150 mM NaCl, 10 mM Tris·HCl (pH 7.4), 1 mM EGTA, 1 protease inhibitor tablet (Roche) per 100 ml of buffer] and centrifuged again at 4°C and 15,000 g for 30 min. The nuclear protein-enriched samples were stored at Ϫ80°C until Western blots were run.
Protein concentration was determined using the DC Assay method (Bio-Rad). All Western blots were performed with 40 g total protein per lane with protein from a single SS-16 BN /Mcwi rat to normalize protein expression in each blot. Equivalent protein loading was first assessed by Ponceau S (Sigma) staining of the membrane prior to blotting. Primary antibodies (VEGF 1:200, BD Pharmingen 55439; Flt-1 1:1,000, Santa Cruz Biotechnology, sc-316; catalase 1:2,000, Sigma C-0979; 1:2,000 SOD-2, Santa Cruz Biotechnology, sc-18503; JunD 1:200 Santa Cruz Biotechnology, sc-74; and Nrf-2 1:200 Santa Cruz Biotechnology, sc-722) in blocking solution followed by appropriate horseradish peroxidase-conjugated secondary antibodies and SuperSignal West Dura or Femto (JunD and Nrf2 only) Chemiluminescent Substrate (Thermo Scientific: #34076 or #34094, respectively) were used for protein detection. Due to variability in expression of traditional housekeeping genes in under pathological and physiological conditions (9) membranes were subjected to Coomassie blue staining to confirm equivalent protein loading per lane, as previously described (19) . Protein expression was determined from scanned films by subtracting the background integrated optical densitometry from that of the protein band specific signal (Metamorph Software, Molecular Devices).
Cardiomyocyte isolation and culture. A total of four separate isolations of hearts from neonatal SS/Mcwi and SS-16
BN /Mcwi strains were completed. Rat pups (1-3 days old) were anesthetized on ice and decapitated before the heart was excised. The heart was placed in room-temperature PBS (without Ca 2ϩ and Mg 2ϩ ) pH 7.4 and cleared of blood. Minced tissue from two or three hearts was com-bined, rinsed in PBS, digested with 1.5 ml of 0.25% Trypsin (Invitrogen) for 15 min at 37°C, and then rinsed with 37.5 U/ml collagenase (Worthington Biochemical). Tissue was then digested in 1 ml collagenase by shaking while incubating at 37°C for ϳ4 min. This digestion was repeated 11 times for each sample. Following each digestion the collagenase solution was removed and placed in a culture dish filled with 10% fetal bovine serum (FBS, Sigma) culture medium and incubated for 1 h. The medium was then collected, filtered through a 70 m cell strainer, and pelleted at 100 g for 15 min at room temperature. The pellet, consisting of a mixed population of primarily cardiomyocytes and fibroblasts, was resuspended in 300 l of 10% FBS in DMEM (Fisher, MT10013CM), and cells were seeded at a density of 50,000 cells per well on a 96-well plate.
The adherent cells were switched to a low-serum (1% FBS in DMEM) medium 24 h after seeding. After another 24 h the medium in the treated cells was supplemented with 1, 10, or 100 nM of angiotensin II (AII, Sigma), epidermal growth factor (EGF, R&D Systems), endothelin-1 (ET-1, R&D Systems), fibroblast growth factor (FGF, R&D Systems), insulin-like growth factor (IGF, R&D Systems), or 10% FBS for an additional 48 h. All treatments were completed in triplicate with each isolation. Cells were then fixed in 4% paraformaldehyde, and fluorescence immunocytochemistry was performed for detection of the cardiomyocyte marker tropomyosin [1:10 CH1-s, Developmental Studies Hybridoma Bank (DSHB), Iowa City, IA; 1;200 goat anti-mouse Alexa-488 antibody, Invitrogen] and the fibroblast marker phalloidin (1:40, AlexaFluor 568 phalloidin, Invitrogen). Cardiomyoctes were visualized and photographed at ϫ20 magnification using a TS-100F (Nikon Instruments) microscope and a FLEX (Diagnostic Instruments) camera. The adherent cells were consisted of a mixed population of cardiomyocytes and fibroblasts. The average cardiomyocyte area was calculated from measurements of individual myocytes (6 fields/per replicate, 3 replicates per treatment for each animal) using Metamorph software (Molecular Devices) to determine the growth response to each treatment condition.
Data analysis. Results were expressed as the means Ϯ SE. One-way analysis of variance was used to evaluate all data, except cardiac functional data (see Fig. 5E ) and cardiomyocyte spreading with growth factor treatment (see Fig. 4C ) where Student's t-tests were used to compare groups. Statistical significance was considered P Ͻ 0.05. Table 1 Table S1 ). 1 To identify genetically driven alterations in signaling pathways that may be involved with cardioprotection in the SS-16 BN /Mcwi the 2,515 differentially expressed genes were investigated with IPA software (Ingenuity). The cellular pathways identified with the most differentially expressed genes were ranked by Ϫlog (P value) in the IPA software (Fig. 1) . Using the known phenotypic differences between the strains (capillary density, fibrosis, hypertrophy, and cardiac function) we selected the most relevant of the highly ranked pathways for further analysis. These pathways included: "hypoxic signaling in the cardiovascular system," "VEGF signaling," "PI3-Akt signaling," and "NRF-2 mediated oxidative stress response." The cellular pathways containing the most differentially expressed genes are shown in Fig.  2 ranked by Ϫlog (P value). Several of these pathways were related to cardiac hypertrophy and cardiac function. Select pathways (marked in Fig. 1 ) were investigated in great detail in an effort to relate differential gene expression to the cardiac phenotypes that were observed in the functional and morphological studies. Expression of select proteins within these pathways was quantified by Western blot if the transcript showed strong gene expression differences by microarray and had a known function.
RESULTS

Chip
The pathway for hypoxic signaling in the cardiovascular system contained a total of 71 genes. Upregulated genes from our datasets comprised 12.7% of genes within the pathway and the downregulated comprised another 12.7% of the genes. VEGF-A message was upregulated in the SS-16 BN /Mcwi by 1.66-fold compared with SS/Mcwi. The VEGF signaling pathway ( Fig. 2A) was also analyzed. In addition to VEGF-A, the VEGF receptor Flt-1 message was upregulated in the SS-16 BN / Mcwi by 1.61-fold. Expression of these two proteins measured by Western blot (Fig. 2, B and C, respectively) showed upregulation for VEGF and no change for Flt-1. 1 The online version of this article contains supplemental material. The NRF-2 oxidative stress response pathway (Fig. 3A) (Fig. 3C) , while we saw no differences in SOD-2 protein expression between the three strains (Fig. 3D) .
Cardiomyocyte hypertrophy. Pathway analysis (Fig. 1) identified several hypertrophic growth factor regulated pathways containing many differentially expressed genes. Strain specific hypertrophic responses of neonatal cardiomyocytes were tested using hypertrophic growth factors AII, EGF, ET-1, FGF, and IGF in a cell spreading assay. Cultured SS-16 BN /Mcwi myocytes had a smaller area than those from SS/Mcwi rats in both low and high serum conditions (Fig. 4, A and B) . EGF and ET-1 (10 nM in 1% FBS) induced significantly greater cell spreading in SS-16 BN /Mcwi than SS/Mcwi cardiomyocytes (Fig. 4C) . There was no difference in cell area between (Fig. 5, C and D) . Cardiac dimension and functional data were obtained by left ventricular echocardiography (Fig. 5E) . The adaptive changes in diastolic wall thickness, systolic wall thickness, stroke volume, fractional shortening, and heart rate that occurred with 1K1C were all significantly different between the SS-16 BN /Mcwi and SS-13 BN /Mcwi rats despite similar systolic blood pressures (*P Ͻ 0.05, t-test).
DISCUSSION
The goal of the current studies was to explore and characterize pathways involved in cardioprotection in the SS-16 BN / Mcwi at both the molecular and phenotypic levels. To achieve this we used microarray-based gene expression analysis of left ventricle tissue from naïve animals to identify cellular signaling pathways associated with the distinct phenotypic differences in the SS-16 BN Oxidative stress has emerged as an important determinant of cardiac phenotypes associated with hypertrophy, heart failure, and aging. It has been shown to play a role in the development of several phenotypes associated with heart failure such as remodeling (8, 16) , attenuated calcium sensitivity of the myofibers (17, 31) , and reduced contractile efficiency (3, 6) . This concept is supported by the observed decreases in antioxidant levels (5, 28, 30) during the transition from compensated hypertrophy to failure. A recent study by Qin et al. (24) suggests that elevated hydrogen peroxide (H 2 O 2 ) levels play a role in this transition process. Pathway analysis of our microarray data suggests that Mcwi by microarray and Western blot analysis. VEGF is an angiogenic factor that has been shown to control blood vessel growth during embryonic development (9, 33) . VEGF also stimulates endothelial cells to migrate and proliferate during the growth of new blood vessels after embryonic development (28) (25, 26) .
While the results of this study cannot directly attribute the cardioprotection observed in the SS-16 BN /Mcwi rat to higher protein expression of the chromosome 16 gene JunD, we did find higher protein expression of the functionally linked transcription factor Nrf2 (on rat chromosome 3). JunD and Nrf2 are tightly linked and can help protect the heart from pathological remodeling and fibrosis through suppression of oxidative stress and other mechanisms (13, 22) . Both transcription factors have both been shown to activate antioxidant response elements within the promoter regions of antioxidant responsive genes (14, 34) to induce transcription, with Nrf2 physically interacting with JunD prior to binding (36) . We 
